Literature DB >> 24100128

Treatment of hypomagnesemia.

John Ayuk1, Neil J L Gittoes2.   

Abstract

Serum magnesium concentration is determined by the interplay of intestinal absorption and renal excretion. Hypomagnesemia can occur as a result of insufficient magnesium intake, increased gastrointestinal or renal loss, or redistribution from extracellular to intracellular compartments. A number of drugs are known to cause hypomagnesemia, including proton pump inhibitors (PPIs). We report the case of a patient with symptomatic hypomagnesemia due to short bowel syndrome and PPI therapy. Investigations revealed low 24-hour urinary magnesium excretion and secondary hypocalcemia. PPI treatment was withdrawn and the patient was managed with intravenous and oral magnesium and calcium replacement. This teaching case provides an evidence-based discussion of the treatment of hypomagnesemia.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypomagnesemia; intravenous magnesium sulfate; oral magnesium salts; proton pump inhibitor; treatment

Mesh:

Substances:

Year:  2013        PMID: 24100128     DOI: 10.1053/j.ajkd.2013.07.025

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.

Authors:  Geoffrey Cheminet; Gabrielle Clain; Anne-Sophie Jannot; Brigitte Ranque; Amélie Passeron; Adrien Michon; Gonzalo De Luna; Jean-Luc Diehl; Stéphane Oudard; Christophe Cellier; Alexandre Karras; Benoit Vedié; Caroline Prot-Bertoye; Jacques Pouchot; Jean-Benoît Arlet
Journal:  Intern Emerg Med       Date:  2018-06-27       Impact factor: 3.397

Review 2.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

Review 3.  Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review.

Authors:  Jonathan Sivakumar
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

4.  Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.

Authors:  P Fatuzzo; G Portale; V Scollo; L Zanoli; Antonio Granata
Journal:  J Nephrol       Date:  2016-05-20       Impact factor: 3.902

Review 5.  Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.

Authors:  Simone Janett; Pietro Camozzi; Gabriëlla G A M Peeters; Sebastiano A G Lava; Giacomo D Simonetti; Barbara Goeggel Simonetti; Mario G Bianchetti; Gregorio P Milani
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

6.  Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia.

Authors:  Sagger Mawri; Edward Gildeh; Namita Joseph; Bobak Rabbani; Bryan Zweig
Journal:  Case Rep Cardiol       Date:  2017-06-05

7.  Seizures Related to Hypomagnesemia: A Case Series and Review of the Literature.

Authors:  Becky Biqi Chen; Chitra Prasad; Marta Kobrzynski; Craig Campbell; Guido Filler
Journal:  Child Neurol Open       Date:  2016-10-27

8.  Magnesium bioavailability from mineral waters with different mineralization levels in comparison to bread and a supplement.

Authors:  Inga Schneider; Theresa Greupner; Andreas Hahn
Journal:  Food Nutr Res       Date:  2017-10-04       Impact factor: 3.894

Review 9.  An overview of diagnosis and management of drug-induced hypomagnesemia.

Authors:  George Liamis; Ewout J Hoorn; Matilda Florentin; Haralampos Milionis
Journal:  Pharmacol Res Perspect       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.